Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services, discusses the role of commercial payers in the shift toward value-based care.
Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services, discusses the role of commercial payers in the shift toward value-based care.
Transcript
What role do commercial payers have in the shift toward value-based care?
I think all insurers have a big role in value-based care and commercial is no different than that. If you think about commercial insurance, often times they’re working with large employers, and those employers need healthy populations and they need to have affordable healthcare for their employees because the employees bear the burden of that. So, I think commercial insurers will need to help us push towards more affordable healthcare and delivering on more wellness and health for their populations.
I think you see that also in the Medicare population. Nationally, you’re seeing more and more experimentation with that, and then in the Medicaid population, depending on your state, you’re seeing a lot of experimentation with that, as well. In New Mexico, we’re a Medicaid expansion state, and we’ve been Managed Medicaid for well over 20 years. So, we really work closely with the state to design benefits that really improve the health of the population.
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Following Roe v Wade Overturn, Research Focuses on Male Contraceptives
May 6th 2024Stephanie T. Page, MD, PhD, UW Medicine Diabetes Institute, presented on ongoing research and growing interest in new male contraceptive options, such as an oral pill and a hormonal transdermal gel, at the American Urological Association 2024 Annual Meeting.
Read More